Israel-based Panaxia Pharmaceutical Industries announced last May that it was teaming up with Ultra Health, a licensed MMJ business in New Mexico. The companies revealed this week in a joint statement that the new facility, in Bernalillo, New Mexico, has begun production, according to the Post.

The plant will focus on 18 smokeless MMJ products that are designed to be more scientifically precise for patients who are looking for reliable and repeatable dosages, the Post reported. The base of the product line is made in Israel and then shipped to the United States, and cannabis is added at the New Mexico facility.

The plant was constructed in under six months, and Panaxia is already looking to set up a similar operation in Nevada, the Post reported. Ultra Health has facilities already in both Nevada and Arizona.